InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (45 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
45
T+90 hit rate
75%
T+90 mean return
+9.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by RYAN ARTHUR F, Director. Officer active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 50 disclosures have been logged. Breakdown: 0 buy · 45 sells. Total volume traded: €231k. Activity tracked since 14 June 2021. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations50 total
200 shares@ US$650.15Common StockSEC:0001187443-26-000010:0
166 shares0Common StockSEC:0001968202-25-000007:0
3 shares@ US$1,041.352.4% of flowCommon StockSEC:0001968202-24-000130:0
4 shares@ US$1,166.523.6% of flowCommon StockSEC:0001968202-24-000124:0
1 shares@ US$1,100.030.9% of flowCommon StockSEC:0001968202-24-000111:0
1 shares@ US$1,053.220.8% of flowCommon StockSEC:0001968202-24-000110:0
3 shares@ US$1,047.112.5% of flowCommon StockSEC:0001968202-24-000105:0
2 shares@ US$979.401.5% of flowCommon StockSEC:0001968202-24-000099:0
3 shares@ US$889.502.1% of flowCommon StockSEC:0001883850-24-000017:0
2 shares@ US$957.781.5% of flowCommon StockSEC:0001968202-24-000090:0
1 shares@ US$967.500.8% of flowCommon StockSEC:0001968202-24-000084:0
1 shares@ US$939.530.7% of flowCommon StockSEC:0001968202-24-000048:0
1 shares@ US$873.910.7% of flowCommon StockSEC:0001968202-24-000025:0
1 shares@ US$809.030.6% of flowCommon StockSEC:0001968202-23-000044:0
6 shares@ US$824.593.9% of flowCommon StockSEC:0001968202-23-000039:0
2 shares@ US$732.761.1% of flowCommon StockSEC:0001883850-23-000075:0
1 shares@ US$710.090.6% of flowCommon StockSEC:0001968202-23-000016:0
2 shares@ US$730.031.2% of flowCommon StockSEC:0001883850-23-000073:0
16 shares@ US$802.6710.0% of flowCommon StockSEC:0001968202-23-000011:0
7 shares@ US$816.584.5% of flowCommon StockSEC:0001968202-23-000006:0
5 shares@ US$758.203.1% of flowCommon StockSEC:0001883850-23-000054:0
2 shares@ US$752.111.2% of flowCommon StockSEC:0001883850-23-000031:0
14 shares@ US$721.488.1% of flowCommon StockSEC:0001883850-23-000023:0
3 shares@ US$752.571.8% of flowCommon StockSEC:0001883850-22-000104:0
2 shares@ US$750.001.3% of flowCommon StockSEC:0001883850-22-000088:0
25 of 50 declarations
About RYAN ARTHUR F
Public sources indicate that Arthur F. Ryan has been a director of Regeneron Pharmaceuticals since January 2003. Regeneron describes him as the former chief executive officer and chair of Prudential Financial, and says he served as president and chief operating officer of Chase Manhattan Bank from 1990 to 1994, then as a non-executive director of Royal Bank of Scotland Group from 2008 to 2013 and a director of Citizens Financial Group from 2009 to 2019. He serves on Regeneron’s Audit Committee and Corporate Governance and Compliance Committee. Sources : https://investor.regeneron.com/board-directors/arthur-ryan
